| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |